Susceptibility to nontuberculous mycobacterial lung disease: Table 1—
Authors:
- P. SextonPSP. Sexton
- A. C. HarrisonAHA. C. Harrison
- 30 May 2008
- journal article
- review article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 31 (6) , 1322-1333
Abstract
The nontuberculous mycobacteria (NTM) exhibit heterogeneous pathogenicity in humans. Articles on known and potential human factors capable of producing susceptibility to NTM lung disease (NTMLD) were identified by a systematic search of the medical literature, and are reviewed in the present study.Patients with pre-existing structural lung disease are known to be at risk of NTMLD. Other susceptible groups have become recognised since the 1980s, in particular middle-aged nonsmokers without previous lung disease (a group including those with Lady Windermere syndrome) and patients with genetically determined defects of cell-mediated immunity, including abnormalities of the interleukin-12/interferon-γ axis, certain human leukocyte antigen alleles, cystic fibrosis transmembrane conductance regulator mutations, and polymorphisms of solute carrier 11A1 (or natural resistance-associated macrophage protein 1) and the vitamin D receptor.Information is also accruing about acquired systemic causes of susceptibility to NTMLD, including inhibitory antibodies directed against interferon-γ, post-menopausal waning of endogenous oestrogen levels, coeliac disease and exposure to use of dietary phyto-oestrogens. It is not known whether immunosuppressive factors, such as oral corticosteroid treatment, chronic renal failure, diabetes mellitus and other known risk factors for pulmonary tuberculosis, are also risk factors for the development of NTMLD. Caution is appropriate in managing such patients.Keywords
This publication has 157 references indexed in Scilit:
- Nontuberculous mycobacterial infection in young children with cystic fibrosisPediatric Pulmonology, 2005
- Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapyArthritis & Rheumatism, 2004
- Pulmonary Mycobacterium xenopi Infection in AIDS Patients Treated with HAART in HungaryEuropean Journal of Clinical Microbiology & Infectious Diseases, 2003
- Prospective study on nontuberculous mycobacteria in patients with and without cystic fibrosisMedical Microbiology and Immunology, 2003
- Sudden Onset of Multiple Painful Erythematous Papules and Pustules—Quiz CaseArchives of Dermatology, 2003
- The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: Results from ATTRACT, a multicenter, randomized, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 2002
- Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivoEuropean Journal of Immunology, 2002
- Non-tuberculous mycobacterial infection in children with cancerEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functionsCytokine, 1995
- Mycobacterium avium intracellulare suppurative thyroiditis in a patient with Hashimoto’s thyroiditisJournal of Endocrinological Investigation, 1994